{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:00:24Z","timestamp":1791925224230,"version":"4.3.4"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T00:00:00Z","timestamp":1653696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T00:00:00Z","timestamp":1653696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The prevalence of cardiovascular disease (CVD) is rapidly increasing in the world. The present study aimed to assess the prevalence and Predictors factors of CVD based on the data of Kherameh cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The present cross-sectional, analytical study was done based on the data of Kherameh cohort study, as a branch of the Prospective Epidemiological Studies in Iran (PERSIAN). The participants consisted of 10,663 people aged 40\u201370\u00a0years. CVD was defined as suffering from ischemic heart diseases including heart failure, angina, and myocardial infarction. Logistic regression was used to model and predict the factors related to CVD. Additionally, the age-standardized prevalence rate (ASPR) of CVD was determined using the standard Asian population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The ASPR of CVD was 10.39% in males (95% CI 10.2\u201310.6%) and 10.21% in females (95% CI 9.9\u201310.4%). The prevalence of CVD was higher among the individuals with high blood pressure (58.3%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) as well as among those who smoked (28.3%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.018), used opium (18.2%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.039), had high triglyceride levels (31.6%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.011), were overweight and obese (66.2%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), were unmarried (83.9%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), were illiterate (64.2%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), were unemployed (60.9%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and suffered from diabetes mellitus (28.1%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The results of multivariable logistic regression analysis showed that the odds of having CVD was 2.25 times higher among the individuals aged 50\u201360\u00a0years compared to those aged 40\u201350\u00a0years, 1.66 folds higher in opium users than in non-opium users, 1.37 times higher in smokers compared to non-smokers, 2.03 folds higher in regular users of sleeping pills than in non-consumers, and 4.02 times higher in hypertensive individuals than in normotensive ones.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The prevalence of CVD was found to be relatively higher in Kherameh (southern Iran) compared to other places. Moreover, old age, obesity, taking sleeping pills, hypertension, drug use, and chronic obstructive pulmonary disease had the highest odds ratios of CVD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-022-02683-w","type":"journal-article","created":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T09:05:43Z","timestamp":1653728743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["The prevalence and predictors of cardiovascular diseases in Kherameh cohort study: a population-based study on 10,663 people in southern Iran"],"prefix":"10.1186","volume":"22","author":[{"given":"Najibullah","family":"Baeradeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Ghoddusi Johari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Moftakhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Rezaeianzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Vahid","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Rezaianzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,28]]},"reference":[{"key":"2683_CR1","doi-asserted-by":"crossref","unstructured":"Zinat Motlagh SF, Chaman R, Ghafari SR, Parisay Z, Golabi MR, Eslami AA, et al. Knowledge, treatment, control, and risk factors for hypertension among adults in Southern Iran. Int J Hypertens. 2015;2015.","DOI":"10.1155\/2015\/897070"},{"key":"2683_CR2","unstructured":"Noncommunicable diseases Fact Sheet. november 2021.World Health Organization. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/noncommunicable-diseases."},{"issue":"3","key":"2683_CR3","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1053\/j.ajkd.2009.06.044","volume":"55","author":"BV Mittal","year":"2010","unstructured":"Mittal BV, Singh AK. Hypertension in the developing world: challenges and opportunities. Am J Kidney Dis. 2010;55(3):590\u20138.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2683_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cpcardiol.2009.10.002","volume":"35","author":"TA Gaziano","year":"2010","unstructured":"Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of coronary heart disease in low-and middle-income countries. Curr Probl Cardiol. 2010;35(2):72\u2013115.","journal-title":"Curr Probl Cardiol"},{"key":"2683_CR5","doi-asserted-by":"crossref","unstructured":"Buettner R, Schunter M, editors. Efficient machine learning based detection of heart disease. In: 2019 IEEE international conference on E-health networking, application & services (HealthCom); 2019: IEEE.","DOI":"10.1109\/HealthCom46333.2019.9009429"},{"issue":"25","key":"2683_CR6","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2683_CR7","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1161\/CIRCULATIONAHA.107.720953","volume":"117","author":"H Hemingway","year":"2008","unstructured":"Hemingway H, Langenberg C, Damant J, Frost C, Py\u00f6r\u00e4l\u00e4 K, Barrett-Connor E. Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries. Circulation. 2008;117(12):1526\u201336.","journal-title":"Circulation"},{"issue":"10159","key":"2683_CR8","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","volume":"392","author":"JD Stanaway","year":"2018","unstructured":"Stanaway JD, Afshin A, Gakidou E, Lim SS, Abate D, Abate KH, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018;392(10159):1923\u201394.","journal-title":"The Lancet"},{"key":"2683_CR9","unstructured":"Cardiovascular disease mortality in the developing countries. World Health Statist Quart 1993; 46: 89-150."},{"key":"2683_CR10","unstructured":"Mohammadi M, Mirzaei M, Karami M. Potential impact fraction of ischemic heart disease associated with diabetes mellitus in Yazd-Iran. 2018."},{"key":"2683_CR11","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.2147\/DMSO.S216791","volume":"12","author":"W Kopp","year":"2019","unstructured":"Kopp W. How western diet and lifestyle drive the pandemic of obesity and civilization diseases. Diabetes Metab Syndr Obesity Targets Ther. 2019;12:2221.","journal-title":"Diabetes Metab Syndr Obesity Targets Ther"},{"issue":"2","key":"2683_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.7196\/SAMJ.8696","volume":"105","author":"H Lalkhen","year":"2015","unstructured":"Lalkhen H, Mash R. Multimorbidity in non-communicable diseases in South African primary healthcare. S Afr Med J. 2015;105(2):134\u20138.","journal-title":"S Afr Med J"},{"key":"2683_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-020-01526-w","volume":"20","author":"A Ghaemian","year":"2020","unstructured":"Ghaemian A, Nabati M, Saeedi M, Kheradmand M, Moosazadeh M. Prevalence of self-reported coronary heart disease and its associated risk factors in Tabari cohort population. BMC Cardiovasc Disord. 2020;20:1\u201310.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"2683_CR14","first-page":"22","volume":"1","author":"M Hasanlo","year":"2017","unstructured":"Hasanlo M, Zeinalzadeh AH, Rabie Siahkali S, Rashtchi V. Frequency of the cardiovascular risk factors and their relationship with nurse\u2019s gender in intensive Care unit and emergency department, Kermanshah, Iran. Iran J Emergency Care. 2017;1(1):22\u201331.","journal-title":"Iran J Emergency Care"},{"issue":"2","key":"2683_CR15","first-page":"59","volume":"9","author":"N Agheli","year":"2005","unstructured":"Agheli N, Assefzadeh S, Rajabi M. The prevalence of cardiovascular risk factors among population aged over 30 years in Rasht and Qazvin. J Inflamm Dis. 2005;9(2):59\u201365.","journal-title":"J Inflamm Dis"},{"key":"2683_CR16","unstructured":"Kooshki A, Mohajeri N, Movahhedi A. Prevalence of Cvd risk factors related to diet in patients referring to Modarres hospital in Tehran in 1379 (1999). 2003."},{"key":"2683_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/VHRM.S97252","volume":"12","author":"RK Zeidan","year":"2016","unstructured":"Zeidan RK, Farah R, Chahine MN, Asmar R, Hosseini H, Salameh P, et al. Prevalence and correlates of coronary heart disease: first population-based study in Lebanon. Vasc Health Risk Manag. 2016;12:75.","journal-title":"Vasc Health Risk Manag"},{"key":"2683_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3389\/fpubh.2019.00411","volume":"7","author":"Y Wang","year":"2020","unstructured":"Wang Y, Li Y, Liu X, Zhang H, Abdulai T, Tu R, et al. Prevalence and influencing factors of coronary heart disease and stroke in Chinese rural adults: the Henan rural cohort study. Front Public Health. 2020;7:411.","journal-title":"Front Public Health"},{"issue":"4","key":"2683_CR19","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/aje\/kwx314","volume":"187","author":"H Poustchi","year":"2018","unstructured":"Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar A-A, Hekmatdoost A, et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): rationale, objectives, and design. Am J Epidemiol. 2018;187(4):647\u201355.","journal-title":"Am J Epidemiol"},{"key":"2683_CR20","unstructured":"Organization WH. Global database on Body Mass Index: BMI Classification. 2006. World Health Organization: Geneva, Switzerland. 2015."},{"issue":"3","key":"2683_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41371-020-0330-8","volume":"35","author":"A Rezaianzadeh","year":"2021","unstructured":"Rezaianzadeh A, Jafari F, Sadeghi SE, Rahimikazerooni S. The prevalence and predictors of pre-hypertension and hypertension in Kherameh cohort study: a population based study on 10,663 persons in south of Iran. J Hum Hypertens. 2021;35(3):257\u201364.","journal-title":"J Hum Hypertens"},{"issue":"1","key":"2683_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/ajh\/hps013","volume":"26","author":"R Gupta","year":"2013","unstructured":"Gupta R, Deedwania PC, Achari V, Bhansali A, Gupta BK, Gupta A, et al. Normotension, prehypertension, and hypertension in urban middle-class subjects in India: prevalence, awareness, treatment, and control. Am J Hypertens. 2013;26(1):83\u201394.","journal-title":"Am J Hypertens"},{"issue":"33","key":"2683_CR23","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"issue":"1","key":"2683_CR24","doi-asserted-by":"publisher","first-page":"23286","DOI":"10.3402\/gha.v7.23286","volume":"7","author":"O Sankoh","year":"2014","unstructured":"Sankoh O, Sharrow D, Herbst K, Whiteson Kabudula C, Alam N, Kant S, et al. The INDEPTH standard population for low-and middle-income countries, 2013. Glob Health Action. 2014;7(1):23286.","journal-title":"Glob Health Action"},{"issue":"1","key":"2683_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","volume":"70","author":"GA Roth","year":"2017","unstructured":"Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1\u201325.","journal-title":"J Am Coll Cardiol"},{"issue":"9710","key":"2683_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0140-6736(09)61794-3","volume":"375","author":"RH Eckel","year":"2010","unstructured":"Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2010;375(9710):181\u20133.","journal-title":"Lancet"},{"key":"2683_CR27","doi-asserted-by":"crossref","unstructured":"Abbasi M, Neishaboury M, Koohpayehzadeh J, Etemad K, Meysamie A, Asgari F, et al. National prevalence of self-reported coronary heart disease and chronic stable angina pectoris: Factor analysis of the underlying cardiometabolic risk factors in the SuRFNCD-2011. Global Heart. 2018;13(2):73\u201382. e1.","DOI":"10.1016\/j.gheart.2018.01.001"},{"issue":"1","key":"2683_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2015.01.027","volume":"241","author":"Y Appelman","year":"2015","unstructured":"Appelman Y, van Rijn BB, Monique E, Boersma E, Peters SA. Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis. 2015;241(1):211\u20138.","journal-title":"Atherosclerosis"},{"issue":"5","key":"2683_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063347","volume":"8","author":"TS Mikkola","year":"2013","unstructured":"Mikkola TS, Gissler M, Merikukka M, Tuomikoski P, Ylikorkala O. Sex differences in age-related cardiovascular mortality. PLoS ONE. 2013;8(5): e63347.","journal-title":"PLoS ONE"},{"issue":"1","key":"2683_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/eurpub\/ckq022","volume":"21","author":"EM Crimmins","year":"2011","unstructured":"Crimmins EM, Kim JK, Sol\u00e9-Aur\u00f3 A. Gender differences in health: results from SHARE, ELSA and HRS. Eur J Pub Health. 2011;21(1):81\u201391.","journal-title":"Eur J Pub Health"},{"key":"2683_CR31","doi-asserted-by":"publisher","first-page":"100025","DOI":"10.1016\/j.medntd.2019.100025","volume":"4","author":"Z Gao","year":"2019","unstructured":"Gao Z, Chen Z, Sun A, Deng X. Gender differences in cardiovascular disease. Med Novel Technol Devices. 2019;4:100025.","journal-title":"Med Novel Technol Devices"},{"issue":"3","key":"2683_CR32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1053\/beog.2002.0282","volume":"16","author":"GI Gorodeski","year":"2002","unstructured":"Gorodeski GI. Update on cardiovascular disease in post-menopausal women. Best Pract Res Clin Obstet Gynaecol. 2002;16(3):329\u201355.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2683_CR33","doi-asserted-by":"crossref","unstructured":"Investigators WGftWsHI, Investigators WGftWsHI. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321\u201333.","DOI":"10.1001\/jama.288.3.321"},{"issue":"8","key":"2683_CR34","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1161\/CIRCULATIONAHA.118.035550","volume":"139","author":"SA Peters","year":"2019","unstructured":"Peters SA, Muntner P, Woodward M. Sex differences in the prevalence of, and trends in, cardiovascular risk factors, treatment, and control in the United States, 2001 to 2016. Circulation. 2019;139(8):1025\u201335.","journal-title":"Circulation"},{"issue":"4","key":"2683_CR35","doi-asserted-by":"publisher","first-page":"447","DOI":"10.7326\/0003-4819-85-4-447","volume":"85","author":"WB Kannel","year":"1976","unstructured":"Kannel WB, Hjortland MC, McNAMARA PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med. 1976;85(4):447\u201352.","journal-title":"Ann Intern Med"},{"issue":"4","key":"2683_CR36","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cger.2009.07.007","volume":"25","author":"A Yazdanyar","year":"2009","unstructured":"Yazdanyar A, Newman AB. The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. Clin Geriatr Med. 2009;25(4):563.","journal-title":"Clin Geriatr Med"},{"issue":"8","key":"2683_CR37","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1161\/CIRCRESAHA.111.246876","volume":"110","author":"BJ North","year":"2012","unstructured":"North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res. 2012;110(8):1097\u2013108.","journal-title":"Circ Res"},{"issue":"8","key":"2683_CR38","doi-asserted-by":"publisher","first-page":"e020282","DOI":"10.1136\/bmjopen-2017-020282","volume":"8","author":"W Hinton","year":"2018","unstructured":"Hinton W, McGovern A, Coyle R, Han TS, Sharma P, Correa A, et al. Incidence and prevalence of cardiovascular disease in English primary care: a cross-sectional and follow-up study of the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC). BMJ Open. 2018;8(8):e020282.","journal-title":"BMJ Open"},{"key":"2683_CR39","doi-asserted-by":"crossref","unstructured":"Csige I, Ujv\u00e1rosy D, Szab\u00f3 Z, L\u0151rincz I, Paragh G, Harangi M, et al. The impact of obesity on the cardiovascular system. Journal of diabetes research. 2018;2018.","DOI":"10.1155\/2018\/3407306"},{"issue":"21","key":"2683_CR40","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","volume":"53","author":"CJ Lavie","year":"2009","unstructured":"Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53(21):1925\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"4 Suppl","key":"2683_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1353\/hpu.2011.0166","volume":"22","author":"L Akil","year":"2011","unstructured":"Akil L, Ahmad HA. Relationships between obesity and cardiovascular diseases in four southern states and Colorado. J Health Care Poor Underserved. 2011;22(4 Suppl):61.","journal-title":"J Health Care Poor Underserved"},{"issue":"41","key":"2683_CR42","doi-asserted-by":"publisher","first-page":"16263","DOI":"10.1073\/pnas.0700933104","volume":"104","author":"KS Reddy","year":"2007","unstructured":"Reddy KS, Prabhakaran D, Jeemon P, Thankappan K, Joshi P, Chaturvedi V, et al. Educational status and cardiovascular risk profile in Indians. Proc Natl Acad Sci. 2007;104(41):16263\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"2683_CR43","first-page":"1296","volume":"78","author":"Z Yu","year":"2000","unstructured":"Yu Z, Nissinen A, Vartiainen E, Song G, Guo Z, Zheng G, et al. Associations between socioeconomic status and cardiovascular risk factors in an urban population in China. Bull World Health Organ. 2000;78:1296\u2013305.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"2683_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-11-567","volume":"11","author":"MS Pednekar","year":"2011","unstructured":"Pednekar MS, Gupta R, Gupta PC. Illiteracy, low educational status, and cardiovascular mortality in India. BMC Public Health. 2011;11(1):1\u201312.","journal-title":"BMC Public Health"},{"issue":"6","key":"2683_CR45","doi-asserted-by":"publisher","first-page":"559","DOI":"10.7861\/clinmedicine.6-6-559","volume":"6","author":"M Marmot","year":"2006","unstructured":"Marmot M. Health in an unequal world: social circumstances, biology and disease. Clin Med. 2006;6(6):559.","journal-title":"Clin Med"},{"issue":"6","key":"2683_CR46","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1161\/01.CIR.97.6.596","volume":"97","author":"KS Reddy","year":"1998","unstructured":"Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998;97(6):596\u2013601.","journal-title":"Circulation"},{"key":"2683_CR47","unstructured":"Pearson TA, Siscovick D, Vinicor F, Wilson PF, Fortmann SP, Ford E, et al., editors. Cardiovascular disease. In Disease Control Priorities in Developing Countries; 1993: Citeseer."},{"issue":"1","key":"2683_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ahj.2003.11.027","volume":"148","author":"K Okrainec","year":"2004","unstructured":"Okrainec K, Banerjee DK, Eisenberg MJ. Coronary artery disease in the developing world. Am Heart J. 2004;148(1):7\u201315.","journal-title":"Am Heart J"},{"issue":"11","key":"2683_CR49","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nrcardio.2009.163","volume":"6","author":"AM Clark","year":"2009","unstructured":"Clark AM, DesMeules M, Luo W, Duncan AS, Wielgosz A. Socioeconomic status and cardiovascular disease: risks and implications for care. Nat Rev Cardiol. 2009;6(11):712\u201322.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"2683_CR50","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/archinte.163.2.205","volume":"163","author":"NT Ayas","year":"2003","unstructured":"Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A, et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med. 2003;163(2):205\u20139.","journal-title":"Arch Intern Med"},{"issue":"2","key":"2683_CR51","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/sleep\/6.2.102","volume":"6","author":"DL Wingard","year":"1983","unstructured":"Wingard DL, Berkman LF. Mortality risk associated with sleeping patterns among adults. Sleep. 1983;6(2):102\u20137.","journal-title":"Sleep"},{"issue":"S660","key":"2683_CR52","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.0954-6820.1982.tb00362.x","volume":"211","author":"M Partinen","year":"1982","unstructured":"Partinen M, Putkonen P, Kaprio J, Koskenvuo M, Hilakivi I. Sleep disorders in relation to coronary heart disease. Acta Med Scand. 1982;211(S660):69\u201383.","journal-title":"Acta Med Scand"},{"issue":"1","key":"2683_CR53","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2174\/157340310790231635","volume":"6","author":"M Nagai","year":"2010","unstructured":"Nagai M, Hoshide S, Kario K. Sleep duration as a risk factor for cardiovascular disease-a review of the recent literature. Curr Cardiol Rev. 2010;6(1):54\u201361.","journal-title":"Curr Cardiol Rev"},{"issue":"1","key":"2683_CR54","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1001\/archpsyc.1979.01780010109014","volume":"36","author":"DF Kripke","year":"1979","unstructured":"Kripke DF, Simons RN, Garfinkel L, Hammond EC. Short and long sleep and sleeping pills: is increased mortality associated? Arch Gen Psychiatry. 1979;36(1):103\u201316.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"2683_CR55","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1089\/jpm.2008.9690","volume":"12","author":"MD Carlson","year":"2009","unstructured":"Carlson MD, Morrison RS. Study design, precision, and validity in observational studies. J Palliat Med. 2009;12(1):77\u201382.","journal-title":"J Palliat Med"},{"issue":"4","key":"2683_CR56","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.pcad.2019.07.001","volume":"62","author":"AJ Nelson","year":"2019","unstructured":"Nelson AJ, Peterson ED, Pagidipati NJ. Atherosclerotic cardiovascular disease and heart failure: determinants of risk and outcomes in patients with diabetes. Prog Cardiovasc Dis. 2019;62(4):306\u201314.","journal-title":"Prog Cardiovasc Dis"},{"issue":"18","key":"2683_CR57","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","volume":"97","author":"PW Wilson","year":"1998","unstructured":"Wilson PW, D\u2019Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837\u201347.","journal-title":"Circulation"},{"issue":"8","key":"2683_CR58","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","volume":"3","author":"W Chen","year":"2015","unstructured":"Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(8):631\u20139.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"2683_CR59","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.3945\/ajcn.112.037903","volume":"96","author":"ES Eshak","year":"2012","unstructured":"Eshak ES, Iso H, Kokubo Y, Saito I, Yamagishi K, Inoue M, et al. Soft drink intake in relation to incident ischemic heart disease, stroke, and stroke subtypes in Japanese men and women: the Japan Public Health Centre\u2013based study cohort I. Am J Clin Nutr. 2012;96(6):1390\u20137.","journal-title":"Am J Clin Nutr"},{"key":"2683_CR60","doi-asserted-by":"crossref","unstructured":"Kokubo Y, Matsumoto C. Hypertension is a risk factor for several types of heart disease: review of prospective studies. Hypertension: from basic research to clinical practice. 2016:419\u201326.","DOI":"10.1007\/5584_2016_99"},{"key":"2683_CR61","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.phrs.2017.11.003","volume":"129","author":"SE Kjeldsen","year":"2018","unstructured":"Kjeldsen SE. Hypertension and cardiovascular risk: general aspects. Pharmacol Res. 2018;129:95\u20139.","journal-title":"Pharmacol Res"},{"issue":"5","key":"2683_CR62","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1164\/rccm.201512-2480OC","volume":"194","author":"FM Franssen","year":"2016","unstructured":"Franssen FM, Soriano JB, Roche N, Bloomfield PH, Brusselle G, Fabbri LM, et al. Lung function abnormalities in smokers with ischemic heart disease. Am J Respir Crit Care Med. 2016;194(5):568\u201376.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"2683_CR63","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1164\/rccm.201604-0690SO","volume":"194","author":"S Roversi","year":"2016","unstructured":"Roversi S, Fabbri LM, Sin DD, Hawkins NM, Agusti A. Chronic obstructive pulmonary disease and cardiac diseases. An urgent need for integrated care. Am J Respir Crit Care Med. 2016;194(11):1319\u201336.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"2683_CR64","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1136\/thx.2009.128082","volume":"65","author":"JR Feary","year":"2010","unstructured":"Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010;65(11):956\u201362.","journal-title":"Thorax"},{"issue":"9","key":"2683_CR65","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-007824","volume":"5","author":"KJ Rothnie","year":"2015","unstructured":"Rothnie KJ, Yan R, Smeeth L, Quint JK. Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMJ Open. 2015;5(9): e007824.","journal-title":"BMJ Open"},{"issue":"3","key":"2683_CR66","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1164\/rccm.201505-0962OC","volume":"193","author":"ML Portegies","year":"2016","unstructured":"Portegies ML, Lahousse L, Joos GF, Hofman A, Koudstaal PJ, Stricker BH, et al. Chronic obstructive pulmonary disease and the risk of stroke. The Rotterdam Study. Am J Respir Crit Care Med. 2016;193(3):251\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2683_CR67","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.annepidem.2005.04.008","volume":"16","author":"SM Curkendall","year":"2006","unstructured":"Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring E Jr, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada: cardiovascular disease in COPD patients. Ann Epidemiol. 2006;16(1):63\u201370.","journal-title":"Ann Epidemiol"},{"key":"2683_CR68","doi-asserted-by":"crossref","unstructured":"Bangalore S. Cholesterol variability: a marker for increased risk or a risk factor? European heart journal. 2017.","DOI":"10.1093\/eurheartj\/ehx656"},{"issue":"2","key":"2683_CR69","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/00043798-199604000-00014","volume":"3","author":"JE Hokanson","year":"1996","unstructured":"Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a metaanalysis of population-based prospective studies. J Cardiovasc Risk. 1996;3(2):213\u20139.","journal-title":"J Cardiovasc Risk"},{"issue":"11","key":"2683_CR70","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/archinte.167.11.1130","volume":"167","author":"EF Elsayed","year":"2007","unstructured":"Elsayed EF, Tighiouart H, Griffith J, Kurth T, Levey AS, Salem D, et al. Cardiovascular disease and subsequent kidney disease. Arch Intern Med. 2007;167(11):1130\u20136.","journal-title":"Arch Intern Med"},{"issue":"9","key":"2683_CR71","first-page":"1657","volume":"66","author":"J Minami","year":"2008","unstructured":"Minami J, Ishimitsu T, Sudo Y, Matsuoka H. Chronic kidney disease (CKD) as an independent risk factor for cardiovascular disease (CVD). Nihon rinsho Japanese J Clin Med. 2008;66(9):1657\u201363.","journal-title":"Nihon rinsho Japanese J Clin Med"},{"issue":"7","key":"2683_CR72","doi-asserted-by":"publisher","first-page":"e003328","DOI":"10.1161\/JAHA.116.003328","volume":"5","author":"J Lu","year":"2016","unstructured":"Lu J, Mu Y, Su Q, Shi L, Liu C, Zhao J, et al. Reduced kidney function is associated with cardiometabolic risk factors, prevalent and predicted risk of cardiovascular disease in Chinese adults: results from the REACTION study. J Am Heart Assoc. 2016;5(7):e003328.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"2683_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-020-01788-4","volume":"21","author":"P Khalili","year":"2021","unstructured":"Khalili P, Ayoobi F, Mohamadi M, Jamalizadeh A, La Vecchia C, Esmaeili-Nadimi A. Effect of opium consumption on cardiovascular diseases\u2013a cross-sectional study based on data of Rafsanjan cohort study. BMC Cardiovasc Disord. 2021;21(1):1\u201311.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"2683_CR74","first-page":"585","volume":"4","author":"MRK Niaki","year":"2013","unstructured":"Niaki MRK, Hamid M, Farshidi F, Mohammadpour M, Omran MTS. Evaluation of the role of opium addiction in acute myocardial infarction as a risk factor. Caspian J Intern Med. 2013;4(1):585.","journal-title":"Caspian J Intern Med"},{"key":"2683_CR75","doi-asserted-by":"crossref","unstructured":"Sabzi F, Zokaei AH, Moloudi AR. Predictors of atrial fibrillation following coronary artery bypass grafting. Clinical Medicine Insights: Cardiology. 2011;5:CMC. S7170.","DOI":"10.4137\/CMC.S7170"},{"issue":"10","key":"2683_CR76","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.amjcard.2004.01.072","volume":"93","author":"M Marmor","year":"2004","unstructured":"Marmor M, Penn A, Widmer K, Levin RI, Maslansky R. Coronary artery disease and opioid use. Am J Cardiol. 2004;93(10):1295\u20137.","journal-title":"Am J Cardiol"},{"key":"2683_CR77","doi-asserted-by":"crossref","unstructured":"AZIMZADE SB, Gholamreza Y, Narooey S. A case-control study of effect of opium addiction on myocardial infarction. 2005.","DOI":"10.3844\/ajassp.2005.1134.1135"},{"key":"2683_CR78","unstructured":"Hosseini SA, Abdollahi A, Behnampour N, Salehi A. The relationship between coronary risk factors and coronary artery involvement based on angiogrpahy findings. Koomesh. 2012;14(1)."},{"issue":"1","key":"2683_CR79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13011-019-0249-7","volume":"15","author":"S Nakhaee","year":"2020","unstructured":"Nakhaee S, Ghasemi S, Karimzadeh K, Zamani N, Alinejad-Mofrad S, Mehrpour O. The effects of opium on the cardiovascular system: a review of side effects, uses, and potential mechanisms. Substance Abuse Treat Prevent policy. 2020;15(1):1\u201313.","journal-title":"Substance Abuse Treat Prevent policy"},{"issue":"17","key":"2683_CR80","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1055\/s-0031-1280017","volume":"77","author":"SK Hosseini","year":"2011","unstructured":"Hosseini SK, Masoudkabir F, Vasheghani-Farahani A, Alipour-Parsa S, Fathollahi MS, Rahimi-Foroushani A, et al. Opium consumption and coronary atherosclerosis in diabetic patients: a propensity score-matched study. Planta Med. 2011;77(17):1870\u20135.","journal-title":"Planta Med"},{"issue":"10","key":"2683_CR81","first-page":"1937","volume":"48","author":"SA Moezi","year":"2019","unstructured":"Moezi SA, Azdaki N, Kazemi T, Moghaddam HRM, Partovi N, Hamidi F, et al. Effects of opium use on cardiovascular mortality: a critical appraisal of a topic. Iran J Public Health. 2019;48(10):1937.","journal-title":"Iran J Public Health"},{"issue":"2","key":"2683_CR82","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11673-017-9784-y","volume":"14","author":"S Matthews","year":"2017","unstructured":"Matthews S, Dwyer R, Snoek A. Stigma and self-stigma in addiction. J Bioethical Inquiry. 2017;14(2):275\u201386.","journal-title":"J Bioethical Inquiry"},{"key":"2683_CR83","doi-asserted-by":"crossref","unstructured":"Hackshaw A, Morris JK, Boniface S, Tang J-L, Milenkovi\u0107 D. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ. 2018;360.","DOI":"10.1136\/bmj.j5855"},{"key":"2683_CR84","doi-asserted-by":"crossref","unstructured":"Roy A, Rawal I, Jabbour S, Prabhakaran D. Tobacco and cardiovascular disease: A summary of evidence. Cardiovascular, Respiratory, and Related Disorders 3rd edition. 2017.","DOI":"10.1596\/978-1-4648-0518-9_ch4"},{"key":"2683_CR85","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.etp.2005.05.010","volume":"57","author":"M Borgerding","year":"2005","unstructured":"Borgerding M, Klus H. Analysis of complex mixtures\u2013cigarette smoke. Exp Toxicol Pathol. 2005;57:43\u201373.","journal-title":"Exp Toxicol Pathol"},{"issue":"10","key":"2683_CR86","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.jacc.2003.12.047","volume":"43","author":"JA Ambrose","year":"2004","unstructured":"Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43(10):1731\u20137.","journal-title":"J Am Coll Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02683-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02683-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02683-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T14:04:05Z","timestamp":1668348245000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02683-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,28]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2683"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02683-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,28]]},"assertion":[{"value":"23 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PERSIAN Cohort Study is being performed in 18 geographical regions of Iran. PERSIAN Cohort Study was approved by the Ethics Committee of the Ministry of Health and Medical Education. This study was in agreement with the Helsinki Declaration and Iranian national guidelines for ethics in research (Reference No. IR.SUMS.REC.1400.612). Besides, written informed consent was obtained from all the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from each participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"244"}}